The efficacy of Cerebrolysin in the treatment of acute ischemic stroke

Research Deputy, Shahid Beheshti University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•patients aged 45 to 85 years, the occurrence of acute cerebral ischemic attack (embolic or thrombotic), hospitalization during 12 hours of first symptoms of stroke, systolic blood pressure less than 200 and diastolic less than 100 mmHg

•recovery of neurologic symptoms after 4 hours of attack, hemorrhagic stroke or the occurrence of stroke in vertebrobasilar system with blood pressure =200/100 mmHg, seizures, Papilledema or rising intracranial pressure (RICP), neck stiffness or symptoms of brain stimulation, the condition of consciousness stupor and coma (GCS = 6), acute myocardial infarction, National Institutes of Health Stroke Scale (NIHSS) less than 7 and more than 24, hepatic or renal failure - heart failure, dementia initial appearance, acute infectious disease, doubt the Involvement in subsequent brain area (posterior circulation), pregnant women, symptoms of progressive neurologic defects, patients who are in other trials, patients received piracetam or calcium channel blockers (CCB), Patients who received r-TPA treatment during first 4 hours of symptoms

发起方

Research Deputy, Shahid Beheshti University of Medical Sciences